Skip to main content
. 2021 Mar 17;17(5):1590–1606. doi: 10.1007/s12015-021-10151-9

Fig. 1.

Fig. 1

Molecular pathways modulated by YY1 in CSCs. Molecular pathways altered by YY1 in CSCs from endometrial, brain, liver, skin, and breast cancers are shown. RER, rough endoplasmic reticulum; EMT, epithelial-mesenchymal transition